Impact of insulin lispro on HbA1c values in insulin pump users

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1463-1326.2000.00108.xPMID 11225746
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?

  1998cited by this paper
• Improvement of HbA1c and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps

  1998cited by this paper
• The emerging role of post‐prandial hyperglycaemic spikes in the pathogenesis of diabetic complications

  1998cited by this paper
• Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment

  1997cited by this paper
• Effectiveness of postprandial Humalog in toddlers with diabetes.

  1997cited by this paper
• Pre‐meal Insulin Analogue Insulin Lispro vs Humulin® R Insulin Treatment in Young Subjects with Type 1 Diabetes

  1996cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• [Lys(B28), Pro(B29)]‐human insulin: Effect of injection time on postprandial glycemia

  1995cited by this paper
• [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

  1991cited by this paper
• The pharmacokinetics of subcutaneous regular insulin in type I diabetic patients: assessment using a glucose clamp technique.

  1986cited by this paper
• Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.

  1980cited by this paper

• Can Faster Aspart Be Used to Optimize Glycemic Control With Insulin Pump Therapy? From Expectations to Lessons Learned After a Year of Use in the United States

  2022cites this paper
• Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.

  2018cites this paper
• A case of insulin allergy successfully managed using multihexamer‐forming insulin degludec combined with liraglutide

  2016cites this paper
• Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.

  2016cites this paper
• Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations

  2012cites this paper
• Insulin analogues: Action profiles beyond glycaemic control

  2008cites this paper
• Effects of psychotropics on glycosylated hemoglobin (HbA1c) in a cohort of bipolar patients.

  2007cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Achieving goal glycosylated hemoglobin levels in type 2 diabetes mellitus: Practical strategies for success with insulin therapy

  2006cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• How well do rapid‐acting insulins work in obese individuals?

  2006cites this paper
• Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.

  2006cites this paper
• Reduced Severe Hypoglycemia with Insulin Glargine in Intensively Treated Adults with Type 1 Diabetes

  2004cites this paper
• Continuous subcutaneous insulin infusion with short‐acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost‐effectiveness

  2004cites this paper
• Glycemic Parameters with Multiple Daily Injections Using Insulin Glargine Versus Insulin Pump

  2004cites this paper
• Insulin Pump Therapy in the Management of Diabetes

  2003cites this paper
• Effects of Rapid-Acting Insulin Analogs on Overall Glycemic Control in Type 1 and Type 2 Diabetes Mellitus

  2003influential citation
• Post‐prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes

  2002cites this paper
• Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.

  2002cites this paper
• New insulins in the treatment of diabetes mellitus.

  2002cites this paper
• The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes.

  2001cites this paper